Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Discover high-quality research tools to investigate GLP-1 mechanisms and next-generation metabolic targets.
OBESITY RESEARCH SOLUTIONSSecoisolariciresinol diglucoside (SDG) is a lignan that has been found in flaxseed with antioxidant, antiproliferative, antidiabetic, and cardioprotective biological activities.1,2,3,4,5,6 It scavenges 2,2-diphenyl-1-picrylhydrazyl (DPPH; Item No. 14805) radicals (IC50 = 78.9 μg/ml) in a cell-free assay and dose-dependently inhibits the growth of SW480 human colon cancer cells in vitro.2,3 Dietary administration of SDG reduces the number of proliferating tumor cells in an MCF-7 human breast cancer mouse xenograft model in the presence of circulating estrogen.4 It also increases insulin and decreases glucose serum levels in rats with diabetes induced by streptozotocin (Item No. 13104) when administered at a dose of 20 mg/kg.5 SDG (20 mg/kg per day) decreases infarct size in rats with myocardial infarction induced by permanent occlusion of the left anterior descending coronary artery.6
WARNING This product is not for human or veterinary use.
1. Potential protective properties of flax lignan secoisolariciresinol diglucoside. Nutr. J. 14:71, (2015).
2. Investigation of in vitro and in vivo antioxidant potential of secoisolariciresinol diglucoside. Mol. Cell Biochem. 373(1-2), 179-187 (2013).
3. Cytostatic inhibition of cancer cell growth by lignan secoisolariciresinol diglucoside. Nutr. Res. 30(11), 762-769 (2010).
4. Comparative effects of sesame seed lignan and flaxseed lignan in reducing the growth of human breast tumors (MCF-
5. Antidiabetic effect of secoisolariciresinol diglucoside in streptozotocin-
6. Secoisolariciresinol diglucoside induces neovascularization-